<?xml version="1.0" encoding="UTF-8"?>
<p>Thirdly, the platform for the detection and point-of-care diagnostics (Sub-Cluster 1-3) is comprised of 16 projects, which are worth 34,526,645 USD. In the US, Columbia University Health Sciences completed a 5 million USD project entitled “Diagnostic and prognostic biomarkers for severe viral lung disease” between 2014 and 2019. Meanwhile, Erasmus Universitair Medisch Centrum Rotterdam in the EU worked on a study between 2014 and 2016 entitled “Early detection of emerging viruses by next generation in situ hybridization” with a budget of 205,891 USD. Between 2015 and 2018, Nihon University of Japan completed its study “Establishment of gene diagnosis of feline infectious peritonitis by the analysis of the viral genome” with expenditures of 132,600 USD (see 
 <xref rid="healthcare-08-00204-t004" ref-type="table">Table 4</xref>).
</p>
